Please try another search
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always...
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always...
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always...
LyondellBasell Industries N.V. (NYSE:LYB) recently announced that Sonatrach Total Entreprise Polymeres Spa (“STEP”) has chosen its Spheripol technology for a 550,000 tons per year...
Applied Industrial Technologies, Inc. (NYSE:AIT) has reported weaker-than-expected results for fourth-quarter fiscal 2019 (ended Jun 30, 2019). Its earnings lagged estimates by 14.29% while sales...
A series of reports on the U.S. economy released on Aug 15 diminish chances of a recession in the near term. The previous day, Wall Street routed after the bond market signaled at an impending...
Tencent Holdings (OTC:TCEHY) reported second-quarter 2019 non-GAAP earnings of 36 cents per share that beat the Zacks Consensus Estimate by a penny.However, revenues of $12.92 billion lagged the...
Aflac (AFL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most...
Arcturus Therapeutics (ARCT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings...
Buckeye Partners L.P. (BPL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting...
Medical Properties Trust, Inc. (NYSE:MPW) — also known as MPT — announced that its board of directors have approved a 4% sequential hike in quarterly dividends to 26 cents.The company...
Roche Holdings (OTC:RHHBY) announced that the FDA has approved Rozlytrek (entrectinib) for the treatment of adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC).The FDA has also...
Technology mutual funds are ideal for investors who seek long-term growth and impressive returns. This sector has a better earnings performance than other sectors, thanks to greater demand for...
Navigating a market this wild can get exhausting. In any case, I’d rather have a market like this than just about every moment of the decade prior. Keep a close eye on banks, financials, and...
Audioeye, Inc. (AEYE) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.17 per share a year ago. These figures are...